| scholarly article | Q13442814 |
| P50 | author | Stephen T Ward | Q57174668 |
| P2093 | author name string | Tariq Ismail | |
| Roy Bicknell | |||
| Victoria L Heath | |||
| Joseph W Wragg | |||
| Henry J M Ferguson | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity | Q24310601 | ||
| The spread of rectal cancer and its effect on prognosis | Q24680199 | ||
| X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor | Q27658372 | ||
| Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis | Q28511809 | ||
| Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel | Q28585536 | ||
| Cancer statistics, 2006 | Q29615133 | ||
| Fcgamma receptors as regulators of immune responses | Q29615584 | ||
| A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction | Q30505755 | ||
| Immuno-oncology: understanding the function and dysfunction of the immune system in cancer | Q33859814 | ||
| NMDA Receptors and Colitis: Basic Science and Clinical Implications. | Q33930017 | ||
| NMDA receptor subunits: diversity, development and disease | Q33950711 | ||
| Glutamate and its receptors in cancer | Q34048497 | ||
| Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice | Q34245416 | ||
| Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors | Q34471652 | ||
| Systemic treatment of colorectal cancer | Q34615998 | ||
| From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment | Q34632695 | ||
| A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels | Q34746019 | ||
| Infusional 5-FU: historical evolution, rationale, and clinical experience. | Q34755264 | ||
| Stress, depression, the immune system, and cancer | Q35909595 | ||
| Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results | Q36097572 | ||
| Systemic therapy for metastatic colorectal cancer: current options, current evidence | Q36186140 | ||
| Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer | Q36481383 | ||
| Immunological aspects of cancer chemotherapy | Q37039588 | ||
| A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis | Q37094321 | ||
| The secret marriage between calcium and tumor angiogenesis. | Q37222628 | ||
| The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights | Q37732574 | ||
| EGFR and KRAS in colorectal cancer | Q37790671 | ||
| Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier | Q37819809 | ||
| Immunosuppressive effects of opioids--clinical relevance | Q37897497 | ||
| Multilevel complexity of calcium signaling: Modeling angiogenesis | Q38035856 | ||
| Management of advanced colorectal cancer, Part 2. | Q38086095 | ||
| Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs). | Q39153671 | ||
| Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells | Q39413297 | ||
| Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. | Q39517637 | ||
| Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling | Q39612036 | ||
| Expression of glutamate receptor subunits in human cancers | Q39837968 | ||
| VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. | Q39938587 | ||
| Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1. | Q39945551 | ||
| Robo4 vaccines induce antibodies that retard tumor growth | Q41687753 | ||
| Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. | Q42140458 | ||
| Isolation of human umbilical vein endothelial cells (HUVEC). | Q43248515 | ||
| Vaccination against tumour blood vessels in colorectal cancer | Q43508586 | ||
| The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development | Q43558334 | ||
| ECSM2, an endothelial specific filamin a binding protein that mediates chemotaxis | Q43913130 | ||
| Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit. | Q43918849 | ||
| Arachidonic acid-induced Ca2+ entry is involved in early steps of tumor angiogenesis | Q46651635 | ||
| Patients with brain metastases from colorectal cancer are not condemned | Q48810030 | ||
| Decision criteria for resolving isotype switching conflicts by B cells. | Q53656220 | ||
| Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. | Q54797303 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 20440-20454 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer | |
| P478 | volume | 7 |
Search more.